Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries - healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Analysts Set New Price Targets
Several analysts have commented on VTR shares. Evercore ISI set a $59.00 price objective on shares of Ventas in a research report on Monday, June 20th. Barclays lowered their price objective on shares of Ventas from $67.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, July 25th. Capital One Financial started coverage on shares of Ventas in a research report on Friday, June 3rd. They issued an "overweight" rating and a $63.00 price objective on the stock. Credit Suisse Group started coverage on shares of Ventas in a research report on Wednesday, June 22nd. They issued an "outperform" rating and a $63.00 price objective on the stock. Finally, Morgan Stanley lowered their price objective on shares of Ventas from $59.00 to $52.00 and set an "equal weight" rating on the stock in a research report on Friday, July 15th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $61.80.
Ventas Price Performance
Ventas stock traded up $0.05 during midday trading on Thursday, reaching $51.55. 1,362,994 shares of the stock were exchanged, compared to its average volume of 2,172,010. The company's fifty day moving average is $51.56 and its 200-day moving average is $54.84. The company has a debt-to-equity ratio of 1.16, a quick ratio of 0.62 and a current ratio of 0.60. The firm has a market cap of $20.61 billion, a PE ratio of 1,031.21, a PEG ratio of 3.23 and a beta of 1.12. Ventas has a 52 week low of $45.44 and a 52 week high of $64.02.
Ventas Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, July 14th. Investors of record on Friday, July 1st were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date was Thursday, June 30th. Ventas's dividend payout ratio (DPR) is presently 3,600.72%.
Insider Buying and Selling
In other Ventas news, CEO Debra A. Cafaro sold 17,400 shares of the business's stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $56.43, for a total value of $981,882.00. Following the completion of the transaction, the chief executive officer now owns 767,960 shares of the company's stock, valued at approximately $43,335,982.80. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.30% of the stock is currently owned by insiders.